- Report
- September 2025
- 91 Pages
Poland
From €4286EUR$4,850USD£3,752GBP
- Report
- September 2024
- 97 Pages
Global
From €4286EUR$4,850USD£3,752GBP
- Report
- September 2024
- 115 Pages
Global
From €3977EUR$4,500USD£3,481GBP
- Report
- July 2024
- 639 Pages
Global
From €3756EUR$4,250USD£3,288GBP
- Report
- July 2023
- 80 Pages
Global
From €4286EUR$4,850USD£3,752GBP
- Report
- July 2021
- 128 Pages
Global
From €3535EUR$4,000USD£3,095GBP
- Report
- September 2020
- 700 Pages
Global
From €4330EUR$4,900USD£3,791GBP
- Drug Pipelines
- January 2020
- 1500 Pages
Global
From €2651EUR$3,000USD£2,321GBP
- Training
- 60 Minutes
Global
- Report
- December 2022
- 60 Pages
Global
From €1767EUR$2,000USD£1,547GBP
- Report
- December 2022
- 52 Pages
Global
From €3093EUR$3,500USD£2,708GBP
- Report
- November 2022
- 53 Pages
Global
From €1767EUR$2,000USD£1,547GBP
- Report
- October 2022
- 307 Pages
Global
From €2209EUR$2,500USD£1,934GBP
- Report
- October 2022
- 53 Pages
Global
From €3093EUR$3,500USD£2,708GBP
- Report
- September 2022
- 65 Pages
Global
From €3093EUR$3,500USD£2,708GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,243USD£3,171GBP
- Report
- July 2024
- 108 Pages
Global
From €3500EUR$4,243USD£3,171GBP
- Report
- July 2024
- 89 Pages
Global
From €3500EUR$4,243USD£3,171GBP
- Report
- July 2024
- 89 Pages
Global
From €3500EUR$4,243USD£3,171GBP
- Report
- March 2024
- 97 Pages
Global
From €3500EUR$4,243USD£3,171GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more